UT-DOXY.ME
18.3.2020 09:02:12 CET | Business Wire | Press release
Doxy.me, a free, secure telemedicine solution, stands ready to meet increased demand for a simple, convenient way for healthcare providers to meet with their patients remotely, promising to improve the health care experience during this critical time.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200318005165/en/
Most telemedicine software products require a lengthy sales cycle, including training, legal review, and software or hardware to install. The process can take weeks to months to get up and running. Doxy.me was designed to be easy to install and simple to use; there are no downloads or apps to install and patients don't need to create accounts. The process is automated, so providers can start practicing telemedicine quickly, even within minutes. This approach means that Doxy.me is perfectly suited to handle the urgent demand for a telemedicine solution during the coronavirus outbreak.
“We’ve seen our sign-ups skyrocket over the past week, and we expect those numbers to keep doubling every day. We’re thrilled that we are in a position to make a difference in the world through our technology,” said Brandon Welch, Founder, Doxy.me. “We believe everyone should have access to telemedicine, and our focus is on assisting the providers and professionals trying to keep people safe and healthy.”
By incorporating standard clinical workflows such as patient check-in and waiting room into the design of Doxy.me, healthcare providers and their patients experience a familiar and natural visit. All the patient needs to start a telemedicine visit is a web link to the doctor’s Doxy.me room using a standard computer.
“Doxy.me brokers an encrypted peer-to-peer connection between a provider and the patient, meaning our server infrastructure won't become overburdened with high video load usage. This means we can scale indefinitely and can provide a free solution to healthcare providers,” said Dylan Turner, COO, Doxy.me.
“Doxy.me is easy to set up, easy to use, and the pricing option is transparent. This means that my busy private-practice office can triage possible coronavirus cases and see patents who are afraid to come in. I was able to set up and implement a telemedicine option overnight,” said Jessica Baker, Baker Family Medical Associates.
About Doxy.me
Founded by Brandon Welch, MS, PhD, and based in Salt Lake City, Utah and Charleston, South Carolina, Doxy.me is making it easier and more affordable for healthcare providers to care for their patients anywhere, including rural and underserved areas. Doxy.me provides patients with a virtual clinic experience that is strongly reminiscent of the traditional consultative model. The company uses state-of-the-art security and encryption protocols, making Doxy.me compliant with HIPAA, GDPR, PHIPA and HITECH requirements, and works on mobile devices (Safari/Chrome) and most desktop browsers. The company also offers a licensed version of Doxy.me for additional features or custom branding.
For more information about Doxy.me or telemedicine, see Doxy.me .
For more information about COVID-19, see the World Health Organization .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200318005165/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Garvan Institute of Medical Research Joins Parse Biosciences’ Certified Service Provider Network15.7.2026 22:00:00 CEST | Press release
Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan's Evercode WT services Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider (CSP) Program. The partnership broadens access to high-quality, scalable single cell sequencing across Australia, the wider Asia-Pacific region, and beyond. Garvan is one of Australia's preeminent medical research institutions, with the Genomics Platform having deep experience in cell sorting, capture, and sequencing. As a Certified Service Provider, Garvan will offer Parse's Evercode WT kits to researchers across the region. "We see a growing number of requests for Parse projects and find the technology easy to implement and run, generating great data," said Chris O'Keeffe, Cellular Genomics Lead at the Garvan Ins
Grafana Labs Named a Leader in 2026 Gartner® Magic Quadrant™ for Observability Platforms and Positioned Furthest in Completeness of Vision15.7.2026 20:21:00 CEST | Press release
Named a Leader for the third consecutive year and placed furthest in vision for the second year in a row, the company has had a landmark year of innovation as observability becomes essential infrastructure for teams building and running AI at scale. Grafana Labs, the company behind the open observability cloud, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Observability Platforms for the third consecutive year, and positioned furthest on the Completeness of Vision axis for the second year running. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715814984/en/ 2026 Gartner® Magic Quadrant™ for Observability Platforms We believe this placement reflects where the market is headed: toward open, composable observability that helps teams in the AI era understand systems that are increasingly complex and agentic, and rapidly scaling thanks to AI-assisted engineering. A Platform Built for the AI Era
Spectro Cloud Raises $100 Million Series D to Help Customers Move AI Infrastructure Into Production Across Enterprise, Public Sector, Neocloud and Sovereign Cloud Environments15.7.2026 18:20:00 CEST | Press release
Growth Equity at Goldman Sachs Alternatives leads oversubscribed round with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus as organizations look to turn AI silicon into business outcomes Spectro Cloud, a leading provider of AI infrastructure management software, today announced it has raised more than $100 million in an oversubscribed Series D funding round led by Growth Equity at Goldman Sachs Alternatives, with strategic participation from AMD Ventures, Ericsson, LG Technology Ventures, and Maximus. The new funding brings Spectro Cloud’s total capital raised to $260 million and will accelerate the company’s mission to help enterprises, public sector organizations, neoclouds and sovereign clouds build and operate production AI infrastructure with greater control over cost, security and governance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715551858/en/ Spectro Cloud raises $
K-Beauty Goes Global: Sales Surge 53% as Korean Innovation Reshapes Beauty Growth15.7.2026 16:00:00 CEST | Press release
New NIQ data shows K-Beauty value sales rose 53% year-over-year and 131% over two years, underscoring how regional beauty trends, social commerce and ingredient-led innovation are reshaping global beauty growth. NIQ (NYSE: NIQ), a global leader in consumer intelligence, today released new findings showing K-Beauty has become a rapidly growing global beauty segment, with value sales up 53% year-over-year and 131% over the past two years. The data points to a broader shift in beauty growth, as regional innovation, social commerce and digitally driven consumer demand increasingly shape what scales globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260715867578/en/ K-Beauty accelerates across global markets In its latest report, K-Beauty Goes Global, NIQ shows how Korean beauty is reshaping consumer expectations, accelerating innovation cycles and redefining competitive dynamics across the global beauty market. What began
Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage15.7.2026 15:00:00 CEST | Press release
Viz Neuro™ Suite, including Viz ICH™ and Viz ICH Plus™, to facilitate rapid detection and care coordination for patients with basal ganglia hemorrhage across trial sites nationwide. Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial, a prospective, multicenter, randomized study evaluating whether the SCUBA technique, an endoscopic, catheter-based approach for ultra-early evacuation of basal ganglia intracerebral hemorrhage (BGH), is a promising alternative to standard medical management to potentially improve functional patient outcomes. The study aims to initiate both randomization and surgical intervention within 120 minutes of key clinical time points, reflecting the urgent nature of intracerebral hemorrhage care. Participating sites will have the ability to leverage the Viz Neuro Suite platform, including Viz ICH and Viz ICH Plus, to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom